1. 30 Mar 2016  |  Global

    Next Generation Diabetes Therapy and Drug Delivery Technologies

    Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory

    Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...


    Special Price $3,712.50 save 25 %

  2. 01 Jul 2015  |  North America

    Analysis of the US and European Diabetes Diagnostics Market

    Constricting Reimbursement Policies Restrain Market Growth

    The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...


    Special Price $5,212.50 save 25 %

  3. 17 Mar 2015  |  Global

    Analysis of the Global Diabetes Drug Delivery Market

    Future Options for End Users

    The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...


    Special Price $3,712.50 save 25 %

  4. The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global ...


    Special Price $2,962.50 save 25 %

  5. 19 Dec 2013  |  Global

    Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

    Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets

    Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...


    Special Price $1,837.50 save 25 %

  6. 23 Sep 2013  |  Asia Pacific

    Analysis of the Global Type 2 Diabetes Therapeutics Market

    Market Opportunities for Differentiated Therapeutics

    The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...


    Special Price $7,500.00 save 25 %

  7. 18 Mar 2013  |  South Asia, Middle East & North Africa

    Indian Diabetes Market

    This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...


    Special Price $3,712.50 save 25 %

  8. 03 Oct 2012  |  South Asia, Middle East & North Africa

    Overview of the Diabetes Therapeutics Market in India

    Diabetes, an Apparent Epidemic in India: Opportunities for Pharmaceutical Companies

    This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the fo...


    Special Price $3,712.50 save 25 %

  9. 13 Jul 2012  |  Europe

    European Diabetes Diagnostics Market

    Growing Diabetes Prevalence Drives Demand

    The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...


    Special Price $3,712.50 save 25 %

  10. This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90...


    Special Price $1,125.00 save 25 %